Gilead’s price gouging for sofosbuvir blocks millions of people from getting treatment NEW YORK/MUNICH/PARIS, SEPTEMBER 11, 2018—This week in Munich, the European Patent Office (EPO) will hear a legal challenge…
A newly agreed draft text of the United Nations political declaration on tuberculosis was released to governments today, affirming the use of flexibilities in international trade rules on intellectual property,…
With negotiations over the final language of a United Nations high level declaration on ending tuberculosis still ongoing, the stakes are high as different TB stakeholders await the outcome. The…
China patent challenge compels Gilead to withdraw key patent claims on sofosbuvir base compound, opening life-saving hepatitis C treatment access for millions I-MAK’s successful patent challenge against Gilead cracks open…
Few weeks before the UN General Assembly High Level Meeting on the fight against Tuberculosis, the EATG issues an open letter: 'As negotiations on the final declaration are now being…
Amsterdam, 26 July 2018 The European AIDS Treatment Group welcomes the landmark decision of the European Court of Justice confirming the invalidity of the patent extension (Supplementary Protection Certificate)…
The fund will launch in the autumn and is intended to support up to 1,000 people in England and Northern Ireland. The fund, which launches this autumn, intends to support…
Program focuses on infectious disease assays - including HIV - for countries where critical testing is needed most MARLBOROUGH, Mass., July 25, 2018 -- Hologic, Inc. (NASDAQ: HOLX) announced today the…
Analysis of laws in Canada and France 26 July 2018 (Amsterdam, the Netherlands) – Research suggests that “end demand” laws are reducing demand for HIV services, according to panellists sharing the…
AIDES and Coalition PLUS welcome the ruling of the Court of Justice of the European Union Read the press release here.
Share the EATG site:
 |  |  |
